CCG-203971
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.
Product Specifications
CAS Number
1443437-74-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
408.88
Molecular Formula
C23H21ClN2O3
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
